Icahn Steals The Future of Enzon Pharmaceuticals [View article]
In addition, a company can be mainly valued by the NPV of it's future cash flows. I fail to see how spinning off the future revenue generators of the company (its discovery pipeline) is not devaluing.
Icahn Steals The Future of Enzon Pharmaceuticals [View article]
Icahn Steals The Future of Enzon Pharmaceuticals [View article]
Icahn Steals The Future of Enzon Pharmaceuticals [View article]